RAMUNNO, Anna
 Distribuzione geografica
Continente #
AS - Asia 3.085
NA - Nord America 1.991
EU - Europa 692
SA - Sud America 94
AF - Africa 12
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 2
Totale 5.883
Nazione #
HK - Hong Kong 2.482
US - Stati Uniti d'America 1.979
SG - Singapore 233
CN - Cina 207
IT - Italia 173
UA - Ucraina 160
RU - Federazione Russa 140
VN - Vietnam 84
BR - Brasile 77
DE - Germania 61
IE - Irlanda 57
FI - Finlandia 37
TR - Turchia 24
KR - Corea 21
SE - Svezia 17
GB - Regno Unito 14
IN - India 12
CA - Canada 8
AT - Austria 6
NL - Olanda 6
AU - Australia 5
FR - Francia 5
CZ - Repubblica Ceca 4
JP - Giappone 4
MA - Marocco 4
PY - Paraguay 4
AR - Argentina 3
BD - Bangladesh 3
CL - Cile 3
MX - Messico 3
UZ - Uzbekistan 3
ZA - Sudafrica 3
CO - Colombia 2
DZ - Algeria 2
EC - Ecuador 2
ES - Italia 2
EU - Europa 2
IL - Israele 2
IQ - Iraq 2
NZ - Nuova Zelanda 2
PL - Polonia 2
SA - Arabia Saudita 2
SK - Slovacchia (Repubblica Slovacca) 2
VE - Venezuela 2
AE - Emirati Arabi Uniti 1
BY - Bielorussia 1
CH - Svizzera 1
EG - Egitto 1
GH - Ghana 1
GR - Grecia 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
IR - Iran 1
KE - Kenya 1
KW - Kuwait 1
LU - Lussemburgo 1
OM - Oman 1
PE - Perù 1
PK - Pakistan 1
SY - Repubblica araba siriana 1
Totale 5.883
Città #
Hong Kong 2.482
Ann Arbor 450
Chandler 197
Jacksonville 182
Woodbridge 178
Princeton 145
Wilmington 106
Dallas 92
Singapore 92
Ashburn 85
Houston 79
Dong Ket 77
Dublin 56
Salerno 49
Beijing 41
Nanjing 39
Boardman 36
Moscow 36
Andover 34
Pellezzano 26
Izmir 18
Fairfield 16
Los Angeles 14
Dearborn 12
Hebei 12
Munich 12
Shenyang 12
Nanchang 10
Jiaxing 9
Changsha 8
Redwood City 8
The Dalles 8
Washington 8
Milan 7
New York 7
Tianjin 7
Chicago 6
Düsseldorf 6
Fisciano 6
Sarno 6
Brooklyn 5
Irpin 5
Menlo Park 5
Naples 5
Norwalk 5
Nuremberg 5
Pune 5
San Francisco 5
Boston 4
Brasília 4
Brisbane 4
Brno 4
Rio de Janeiro 4
Santa Clara 4
Tokyo 4
Vienna 4
Amsterdam 3
Asunción 3
Campina Grande 3
Capri 3
Chennai 3
Falls Church 3
Florence 3
Guangzhou 3
Helsinki 3
Ho Chi Minh City 3
Manchester 3
Mestre 3
Mexico City 3
Seattle 3
State University 3
Tashkent 3
Turku 3
Auckland 2
Bari 2
Belo Horizonte 2
Bratislava 2
Buffalo 2
Cambridge 2
Columbus 2
Incheon 2
Istanbul 2
Jinan 2
Johannesburg 2
London 2
Marigliano 2
Montreal 2
Muro Lucano 2
New Delhi 2
Nola 2
Ottawa 2
Palermo 2
Phoenix 2
Qingdao 2
Quito 2
Rio Grande 2
San Potito Sannitico 2
Santiago 2
Seoul 2
São Paulo 2
Totale 4.851
Nome #
Non-nucleoside HIV-1 reverse transcriptase (RT) inhibitors: Past, present, and future perspectives. 637
Antioxidant activity of diphenylpropionamide derivatives: synthesis, biologicalevaluation and computational analysis. 454
First dual AK​/GSK-​3β inhibitors endowed with antioxidant properties as multifunctional, potential neuroprotective agents 436
Inhibition of human topoisomerase I and anti-proliferative effects on MCF-7 cells by new titanocene complexes 399
Tetrasubstituted Pyrrole Derivative Mimetics of Protein–Protein Interaction Hot-Spot Residues: A Promising Class of Anticancer Agents Targeting Melanoma Cells 381
Anti-Inflammatory, Antioxidant and Crystallographic Studies of N-Palmitoyl-ethanol Amine (PEA) Derivatives 346
Quinoxalinylethylpyridylthioureas (QXPTs) as Potent Non-Nucleoside HIV-1 Reverse Transcriptase (RT) Inhibitors. Further SAR Studies and Identification of a Novel Orally Bioavailable Hydrazine-Based Antiviral Agent. 163
Interaction between Alzheimer's Abeta(25-35) peptide and phospholipid bilayers: The role of cholesterol. 143
Tuning the folding states of beta-amyloid fragment A beta(16-35) with different charge of micelle aggregates 137
Exploring the Photodynamic Properties of Two Antiproliferative Benzodiazopyrrole Derivatives 120
Interaction of a beta-sheet breaker peptide with lipid membranes. 118
New anticancer agents mimicking protein recognition motifs 117
Effect of flavonoids on A beta(25-35)/DLPC vesicle interaction. 114
Specific Targeting of Highly Conserved Residues in the HIV-1 Reverse Transcriptase Primer Grip Region. 2. Stereoselective Interaction to Overcome the Effects of Drug Resistant Mutations 108
Progresses in the pursuit of aldose reductase inhibitors: The structure-based lead optimization step 107
Membrane charge dependent states of the beta-amyloid fragment Abeta (16-35) with differently charged micelle aggregates. 104
A rational approach to the design of selective substrates and potent nontransportable inhibitors of the excitatory amino acid transporter EAAC1 (EAAT3). new glutamate and aspartate analogues as potential neuroprotective agents. 97
Characterization of the 1H-cyclopentapyrimidine-2,4(1H,3H)-dione derivative (S)-CPW399 as a novel, potent, and subtype-selective AMPA receptor full agonist with partial desensitization properties. 93
Pyrrolo[1,5]benzoxa(thia)zepines as a New Class of Potent Apoptotic Agents. Biological Studies and Identification of an Intracellular Location of Their Drug Target. 92
Targeting Relevant HDACs to Support the Survival of Cone Photoreceptors in Inherited Retinal Diseases: Identification of a Potent Pharmacological Tool with In Vitro and In Vivo Efficacy 89
Effects of drug resistance mutations L100I and V106A on the binding of pyrrolobenzoxazepinone nonnucleoside inhibitors to the human immunodeficiency virus type 1 reverse transcriptase catalytic complex. 84
Activation of the c-Jun N-terminal kinase (JNK) signaling pathway is essential during PBOX-6-induced apoptosis in chronic myelogenous leukemia (CML) cells. 82
6-(2-Phenylethyl)nicotine: A novel nicotinic cholinergic receptor ligand. 81
Novel sterically hindered cannabinoid CB1 receptor ligands 79
3-(2-Aminoethyl)pyridine analogs as a4b2 nicotinic cholinergic receptor ligands. 77
Tetra-substituted pyrrole derivatives act as potent activators of p53 in melanoma cells 76
Specific Targeting Highly Conserved Residues in the HIV-1 Reverse Transcriptase Primer Grip Region. Design, Synthesis, and Biological Evaluation of Novel, Potent, and Broad Spectrum NNRTIs with Antiviral Activity 75
Caspase-3 is not essential for DNA fragmentation in MCF-7 cells during apoptosis induced by the pyrrolo-1,5-benzoxazepine, PBOX-6. 72
Synthesis and biological investigation of peptidomimetic SARS-CoV-2 main protease inhibitors bearing quinoline-based heterocycles at P3 71
Design, Synthesis and Biological Evaluation of Novel 2-(N-Aryl or Heteroarylphenylsulfonamido)acetic Acids as Aldose Reductase Inhibitors 70
Pyrrolo-1,5-benzoxazepines: a new class of apoptotic agents. 66
Activation of the Wnt Pathway by Small Peptides: Rational Design, Synthesis and Biological Evaluation. 61
The stereoselective targeting of a specific enzyme-substrate complex is the molecular mechanism for the synergic inhibition of HIV-1 reverse transcriptase by (R)-(-)-PPO464. A novel generation of nonnucleoside inhibitors. 59
Pyrrolobenzoxazepinone derivatives as non-nucleoside HIV-1 RT inhibitors: Further structure-activity relationship studies and identification of more potent broad-spectrum HIV-1 RT inhibitors with antiviral activity. 59
Pyrrolo-1,5-benzoxazepines induce apoptosis in chronic myelogenous leukemia (CML) cells by bypassing the apoptotic suppressor Bcr-Abl. 57
Inhibition of G1 cyclin-dependent kinase activity during growth arrest of human astrocytoma cells by the pyrrolo-1,5-benzoxazepine, PBOX-21. 56
Synthesis of New Molecular Probes for Investigation of Steroid Biosynthesis Induced by Selective Interaction with Peripheral Type Benzodiazepine Receptors (PBR). 56
Azetidin-2-one-based small molecules as dual hHDAC6/HDAC8 inhibitors: Investigation of their mechanism of action and impact of dual inhibition profile on cell viability 55
Phosphonium Salt Displays Cytotoxic Effects Against Human Cancer Cell Lines 54
Exploring the chemical space around chrysin to develop novel vascular CaV1.2 channel blockers, promising vasorelaxant agents 52
Phenol-derived CVFM analog inhibitors of ras farnesyltransferase possessing cellular in vitro activity. 48
Design and synthesis of multifunctional microtubule targeting agents endowed with dual pro-apoptotic and anti-autophagic efficacy 44
Development of potent and selective FAAH inhibitors with improved drug-like properties as potential tools to treat neuroinflammatory conditions 43
Photo-​control of cancer cell growth by benzodiazo N-​substituted pyrrole derivatives 42
Development of 1-(2-aminophenyl)pyrrole-based amides acting as human topoisomerase I inhibitors 40
Ultrasound-Assisted Extraction, Chemical Characterization, and Impact on Cell Viability of Food Wastes Derived from Southern Italy Autochthonous Citrus Fruits 35
Optimization of Potent and Specific Trypanothione Reductase Inhibitors: A Structure-Based Drug Discovery Approach 28
Development of Epigenetic Modifiers with Therapeutic Potential in FMS-Related Tyrosine Kinase 3/Internal Tandem Duplication (FLT3/ITD) Acute Myeloid Leukemia and Other Blood Malignancies 26
5-methyl-2-carboxamidepyrrole-based novel dual mPGES-1/sEH inhibitors as promising anticancer candidates 25
Pioneering first‐in‐class FAAH‐HDAC inhibitors as potentialmultitarget neuroprotective agents 23
Development of Potent and Selective Monoacylglycerol Lipase Inhibitors. SARs, Structural Analysis, and Biological Characterization 23
Extra Virgin Olive Oil Extracts of Indigenous Southern Tuscany Cultivar Act as Anti-Inflammatory and Vasorelaxant Nutraceuticals 21
Bioguided Identification of Polymethoxyflavones as Novel Vascular CaV1.2 Channel Blockers from Citrus Peel 19
Synthetic derivatives of natural cinnamic acids as potential anti-colorectal cancer agents 15
Discovery of p-Trifluoromethylbenzohydrazide Derivatives as Potent Antiviral Agents against Monkeypox Virus 5
Totale 6.034
Categoria #
all - tutte 16.711
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.711


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021266 0 0 30 0 32 12 31 10 37 1 32 81
2021/2022248 0 0 0 0 9 2 3 9 36 38 29 122
2022/2023456 43 45 10 60 72 88 1 30 73 1 22 11
2023/2024305 20 24 15 20 21 39 19 28 46 19 11 43
2024/2025613 23 6 13 23 30 58 131 44 120 30 63 72
2025/20262.733 308 1.820 605 0 0 0 0 0 0 0 0 0
Totale 6.034